With increasing calls for broader access to genetic testing, clinicians are navigating a rapidly shifting landscape. In this session, Dr. Holly Pederson will review current data and evolving guidelines supporting population-based genetic testing for hereditary cancer risk. She’ll address implications for clinical practice, patient selection, risk stratification, and the integration of genetic information into preventive care strategies.

Holly Pederson, MD, MSCP, is a board-certified internal medicine physician and nationally recognized leader in breast health and cancer risk assessment. She serves as the Director of Medical Breast Services at the Cleveland Clinic, where she oversees a high-risk breast program focused on prevention, early detection, and comprehensive care for women at increased risk for breast cancer. Dr. Pederson is a Menopause Society Certified Practitioner and is widely published in the areas of hereditary cancer syndromes, breast density, and risk reduction strategies. A frequent lecturer and educator, she is passionate about advancing evidence-based, patient-centered care in breast medicine.